跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lagundex - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lagundex
Approved
STANDARD
Lagundex
La Croesus Pharma, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9d9aa4f1c7c51a4e
Company
La Croesus Pharma, Inc.
Type
Standard
Approval Details
Approval Id
9d9aa4f1c7c51a4e
Drug Approval Philippines Name
Lagundex
Product Name
Lagundex
Registration Number
HMR-37
Brand Name
Lagundex
Generic Name
Vitex negundo L. (Lagundi Leaf)
Dosage Form
Syrup (Lemon Orange)
Dosage Strength
300 mg/5 mL
Manufacturer
La Croesus Pharma, Inc.
Trader
New Marketlink Pharmaceutical Corporation
Issuance Date
24 January 2024
Expiry Date
18 March 2029
Pharmacologic Category
Herbal Medicine (Anti-Cough/Anti-Asthma)
Classification
Household Remedy (HR)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9d9aa4f1c7c51a4e
Type
Standard
Back to Philippines FDA Approvals